{"title":"Performance Evaluation of the Automated Cell Image Analyzer DI-60 for Leukocyte Differential Count.","authors":"Soon Hee Chang","doi":"10.7754/Clin.Lab.2024.241027","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Sysmex DI-60 system (Sysmex, Kobe, Japan) is an automated cell image analyzer that captures and analyzes cell images. The aim of this study was to evaluate the performance of DI-60 for leukocyte differential count in comparison with manual differential count and XN-20.</p><p><strong>Methods: </strong>A total of 205 samples were analyzed and the agreement between DI-60 pre-classification and post-verification by medical technicians was determined. The correlation and ability to identify clinically important abnormal cells of DI-60 post-verification were then evaluated.</p><p><strong>Results: </strong>The overall agreement of DI-60 pre-classification was 84.7%. The correlation between DI-60 post-verification and manual differential counts was excellent (r2 > 0.85) for neutrophils, lymphocytes, monocytes, and eosinophils, but was very low for basophils (r2 = 0.3759). The DI-60, post-verification, was able to identify clinically important abnormal cells including blasts, promyelocytes, myelocytes, and metamyelocytes with high efficiency (80.8 - 96.3%), but not NRBCs (51.0%). Overall sensitivity was 63.7 - 88.2%, and specificity was 84.3 - 95.5%, excluding NRBCs (43.7%).</p><p><strong>Conclusions: </strong>DI-60 showed excellent pre-classification accuracy and relatively high correlation compared with manual leukocyte differential counts. Although additional verification with a PBS review by experienced medical technicians may still be required, the DI-60 can be used as an efficient screening tool in clinical laboratories.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 3","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical laboratory","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7754/Clin.Lab.2024.241027","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The Sysmex DI-60 system (Sysmex, Kobe, Japan) is an automated cell image analyzer that captures and analyzes cell images. The aim of this study was to evaluate the performance of DI-60 for leukocyte differential count in comparison with manual differential count and XN-20.
Methods: A total of 205 samples were analyzed and the agreement between DI-60 pre-classification and post-verification by medical technicians was determined. The correlation and ability to identify clinically important abnormal cells of DI-60 post-verification were then evaluated.
Results: The overall agreement of DI-60 pre-classification was 84.7%. The correlation between DI-60 post-verification and manual differential counts was excellent (r2 > 0.85) for neutrophils, lymphocytes, monocytes, and eosinophils, but was very low for basophils (r2 = 0.3759). The DI-60, post-verification, was able to identify clinically important abnormal cells including blasts, promyelocytes, myelocytes, and metamyelocytes with high efficiency (80.8 - 96.3%), but not NRBCs (51.0%). Overall sensitivity was 63.7 - 88.2%, and specificity was 84.3 - 95.5%, excluding NRBCs (43.7%).
Conclusions: DI-60 showed excellent pre-classification accuracy and relatively high correlation compared with manual leukocyte differential counts. Although additional verification with a PBS review by experienced medical technicians may still be required, the DI-60 can be used as an efficient screening tool in clinical laboratories.
期刊介绍:
Clinical Laboratory is an international fully peer-reviewed journal covering all aspects of laboratory medicine and transfusion medicine. In addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies. The journal publishes original articles, review articles, posters, short reports, case studies and letters to the editor dealing with 1) the scientific background, implementation and diagnostic significance of laboratory methods employed in hospitals, blood banks and physicians'' offices and with 2) scientific, administrative and clinical aspects of transfusion medicine and 3) in addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies.